AroCell
2003
FOUNDED
PUBLIC
STATUS
1-10
EMPLOYEES
AROC
STOCK SYMBOL
$0.30
SHARE PRICE
(As of Monday Closing)
Description
Developer of biomarker blood tests to support the prognosis and follow up of cancer patients. The company develops and commercializes tests that can be used in the prognosis, monitoring and follow-up of cancer. It has developed a test, the TK 210 ELISA for measuring the enzyme TK1, which is a protein that is elevated in the blood when there is increased cell turnover (cell growth and cell death) within the patient.
Website
Formerly Known As
Xi Bao Research
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
STO
Primary Office
- Uppsala Business Park
- Virdings allé 32 B
- 754 50 Uppsala
- Sweden
+46 070-692 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore AroCell’s full profile, request a free trial.
AroCell Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.25 - $0.90 | $11.7M | $0.30 | -$0.07 | 149K | 39.4M |
AroCell Financials Summary
|
In Thousands,
USD |
TTM
31-Mar-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
FY 2015
31-Dec-2015
|
|---|---|---|---|---|
| Enterprise Value | 8,795 | 11,343 | 18,834 | 31,292 |
| Revenue | 53 | 59 | 6 | |
| EBITDA | (2,065) | (2,021) | (1,076) | (886) |
| Net Income | (2,065) | (2,021) | (1,078) | (886) |
| Total Assets | 5,513 | 6,048 | 7,293 | 8,835 |
| Total Debt | 0 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
AroCell Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore AroCell‘s full profile, request access.
Request full access to PitchBookAroCell Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore AroCell‘s full profile, request access.
Request full access to PitchBookAroCell Executive Team (9)
1 Former Executive
You’re viewing 5 of 9 executives. Get the full list »AroCell Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Erik Walldén | Self | Chairman | 000 0000 | |
| Staffan Eriksson Ph.D | AroCell | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |